Oral antibiotics for bloodstream infection trial
Treatments studied
Part of Infections clinical trials.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and currently in the hospital.
- A blood test must have found a specific type of bacteria called Gram-negative in your bloodstream.
- You must be able to take antibiotics by mouth and not need medications to raise your blood pressure.
- Your infection should be treatable with oral antibiotics, and doctors should expect treatment to last 14 days or less.
- You should not have a brain or spinal cord infection, very low white blood cell count, or be in hospice care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
This trial tests different ways to treat infections in the blood caused by Gram-negative bacteria. It looks at whether reducing antibiotics, switching to pills, or managing central lines improves outcomes while keeping you safe.
This study tests whether children with bloodstream infections can safely switch from IV (through a vein) antibiotics to oral (by mouth) antibiotics earlier than standard practice. The goal is to see if early switching is just as effective and may reduce hospital stays and discomfort.
This trial aims to improve how antibiotics are chosen for patients with resistant bacterial infections in the blood. It uses faster diagnostic tests and expert advice to ensure the most effective treatment.
This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
Hear when a new Gram-negative Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.